These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 24398995

  • 1. Valproic acid substantially downregulated genes folr1, IGF2R, RGS2, COL6A3, EDNRB, KLF6, and pax-3, N-acetylcysteine alleviated most of the induced gene alterations in chicken embryo model.
    Hsieh CL, Chen KC, Ding CY, Tsai WJ, Wu JF, Peng CC.
    Rom J Morphol Embryol; 2013; 54(4):993-1004. PubMed ID: 24398995
    [Abstract] [Full Text] [Related]

  • 2. Multiple point action mechanism of valproic acid-teratogenicity alleviated by folic acid, vitamin C, and N-acetylcysteine in chicken embryo model.
    Hsieh CL, Wang HE, Tsai WJ, Peng CC, Peng RY.
    Toxicology; 2012 Jan 27; 291(1-3):32-42. PubMed ID: 22051200
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Short-time gene expression response to valproic acid and valproic acid analogs in mouse embryonic stem cells.
    Jergil M, Forsberg M, Salter H, Stockling K, Gustafson AL, Dencker L, Stigson M.
    Toxicol Sci; 2011 Jun 27; 121(2):328-42. PubMed ID: 21427059
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Folate receptors and neural tube closure.
    Saitsu H.
    Congenit Anom (Kyoto); 2017 Sep 27; 57(5):130-133. PubMed ID: 28244241
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Identification of early-responsive genes correlated to valproic acid-induced neural tube defects in mice.
    Okada A, Kushima K, Aoki Y, Bialer M, Fujiwara M.
    Birth Defects Res A Clin Mol Teratol; 2005 Apr 27; 73(4):229-38. PubMed ID: 15799026
    [Abstract] [Full Text] [Related]

  • 10. Teratogenic effects mediated by inhibition of histone deacetylases: evidence from quantitative structure activity relationships of 20 valproic acid derivatives.
    Eikel D, Lampen A, Nau H.
    Chem Res Toxicol; 2006 Feb 27; 19(2):272-8. PubMed ID: 16485903
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. An in ovo chicken model to study the systemic and localized teratogenic effects of valproic acid.
    Whitsel AI, Johnson CB, Forehand CJ.
    Teratology; 2002 Oct 27; 66(4):153-63. PubMed ID: 12353211
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Novel targets for valproic acid: up-regulation of melatonin receptors and neurotrophic factors in C6 glioma cells.
    Castro LM, Gallant M, Niles LP.
    J Neurochem; 2005 Dec 27; 95(5):1227-36. PubMed ID: 16313512
    [Abstract] [Full Text] [Related]

  • 19. Valproic acid inhibits histone deacetylase activity and suppresses excitotoxicity-induced GAPDH nuclear accumulation and apoptotic death in neurons.
    Kanai H, Sawa A, Chen RW, Leeds P, Chuang DM.
    Pharmacogenomics J; 2004 Dec 27; 4(5):336-44. PubMed ID: 15289798
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.